Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy.

about

Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy.

Item

http://www.wikidata.org/entity/Q55339581

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@en

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@nl

type

Item

label

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@en

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@nl

prefLabel

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@en

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@nl

P1476

Predictive value of inflammati ...... ith cytoreductive nephrectomy.

@en

P2093

Hironori Fukuda

http://www.w3.org/2001/XMLSchema#string

Kazunari Tanabe

http://www.w3.org/2001/XMLSchema#string

Satoru Shimizu

http://www.w3.org/2001/XMLSchema#string

Toshio Takagi

http://www.w3.org/2001/XMLSchema#string

Tsunenori Kondo

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Immunity, Inflammation, and Cancer

Sorafenib in advanced clear-cell renal-cell carcinoma

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients

Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma.

Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?

Evaluating the yield of medical tests.

P304

14296-14305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24507

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29581844

http://www.w3.org/2001/XMLSchema#string

P932

5865670

http://www.w3.org/2001/XMLSchema#string